Utility of serum free light chain ratio in response definition in patients with multiple myeloma

Blood Adv. 2020 Jan 28;4(2):322-326. doi: 10.1182/bloodadvances.2019001099.

Abstract

  1. Patients with an abnormal sFLC ratio because of LC suppression have outcomes similar to those with a normal ratio.

  2. sFLC ratio has prognostic value in patients achieving CR who have an absence of clonal BMPCs assessed by MFC.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Humans
  • Immunoglobulin Light Chains / therapeutic use*
  • Middle Aged
  • Multiple Myeloma / genetics
  • Multiple Myeloma / therapy*

Substances

  • Immunoglobulin Light Chains